PHIOW - Phio Pharmaceuticals Corp.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
N/A
Enterprise Value 3
N/A
Trailing P/E
N/A
Forward P/E 1
N/A
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
0.30
Enterprise Value/Revenue 3
N/A
Enterprise Value/EBITDA 6
N/A

Trading Information

Stock Price History

Beta (3Y Monthly) 1.61
52-Week Change 3N/A
S&P500 52-Week Change 317.75%
52 Week High 30.0900
52 Week Low 30.0900
50-Day Moving Average 3N/A
200-Day Moving Average 3N/A

Share Statistics

Avg Vol (3 month) 3N/A
Avg Vol (10 day) 3N/A
Shares Outstanding 5N/A
Float 25.84M
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Sep 30, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-38,342.86%

Management Effectiveness

Return on Assets (ttm)-72.47%
Return on Equity (ttm)-170.50%

Income Statement

Revenue (ttm)21k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -7.98M
Net Income Avi to Common (ttm)-7.97M
Diluted EPS (ttm)-0.3680
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)8.71M
Total Cash Per Share (mrq)0.33
Total Debt (mrq)542k
Total Debt/Equity (mrq)7.13
Current Ratio (mrq)4.56
Book Value Per Share (mrq)0.30

Cash Flow Statement

Operating Cash Flow (ttm)-7.84M
Levered Free Cash Flow (ttm)-4.94M